Thailand Board of Investment (BOI) Secretary General Ms. Duangjai Asawachintachit said the recently approved advanced biotechnology projects are reflecting investors increasing interest in Thailand's potential in the biotech sector.

 

NEWS PROVIDED BY Thailand Board of Investment (BOI) 

 

BANGKOK, April 5, 2021 /PRNewswire/ -- The Thailand Board of Investment (BOI) said today it has recently approved new projects in the field of advanced biotechnology, worth a combined 2.4 billion baht (around USD78 million) in investment, reflecting the increased interest of local and foreign investors in the country's biotech sector.

 

"These new and exciting projects reflect investors' continued interest in Thailand biotech capability," Ms. Duangjai Asawachintachit, Secretary General of the BOI. "Adding to our strong agricultural base and biodiversity, Thailand has now also a very strong pool of researchers that allow us to move into advanced technology."

 

Thai Kyowa Biotechnologies Co., Ltd., a producer of amino acids for pharmaceuticals affiliated to Japan's Kirin Holdings, received approval for an advanced biotech project to produce Human Milk Oligosaccharide (HMO), a prebiotic and key ingredient in milk powder for infants and adults, helping to build immunity. The fully Japanese-owned company, located in Thailand's eastern province of Rayong, expects HMO production to start in 2022, mainly for exports.

 

Full story: https://www.prnewswire.com/in/news-releases/thailand-boi-okays-biotech-projects-worth-2-4-bln-baht-in-total-investment-803747920.html

 

-- © Copyright CISION 2021-04-06

 

- Whatever you're going through, the Samaritans are here for you

- Follow Thaivisa on LINE for breaking COVID-19 updates

2.4 bn bht for Japanese co to make babies milk to export? Couldn't this be better spent buying vaccines?

Sure they would. Love the envelope.